Kathleen Sereda Glaub's Net Worth
$787 Thousand
Who is Kathleen Sereda Glaub?
Kathleen Sereda Glaub does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include , IO Biotech, Inc., and Aligos Therapeutics, Inc..
SEC CIK
Kathleen Sereda Glaub's CIK is 0001619612
Past Insider Trading and Trends
2014 was Kathleen Sereda Glaub's most active year for acquiring shares with 1 total transactions. Kathleen Sereda Glaub's most active month to acquire stocks was the month of May. 2018 was Kathleen Sereda Glaub's most active year for disposing of shares, totalling 3 transactions. Kathleen Sereda Glaub's most active month to dispose stocks was the month of August. 2024 saw Kathleen Sereda Glaub paying a total of $0.00 for 45,642 shares, this is the most they've acquired in one year. In 2018 Kathleen Sereda Glaub cashed out on 44,586 shares for a total of $786,606.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.79% | 4.95K |
—
|
—
| 68.48K |
Jun 11
| |||
Form 4
| -18.57% | -14.49K |
$18.83 | -$272,816.25 | 63.53K |
Scheduled
|
Sep 25
| ||
Form 4
| -20.48% | -20.09K |
$17.94 | -$360,389.91 | 78.03K |
Scheduled
|
Sep 19
| ||
Form 4
| -9.25% | -10.00K |
$15.34 | -$153,400.00 | 98.12K |
Scheduled
|
Jul 18
| ||
Form 4
| +5.80% | 5.92K |
—
|
—
| 108.12K |
Jun 11
| |||
Form 4
| +21.23% | 17.89K |
—
|
—
| 102.2K |
Jun 14
| |||
Form 4
| +31.29% | 20.09K |
—
|
—
| 84.3K |
Jun 15
| |||
Form 4
| +47.68% | 20.73K |
—
|
—
| 64.21K |
Jun 10
| |||
Form 4
|
∞
| 43.48K |
—
|
—
| 43.48K |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $0.843
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||